Zuleima Yáñez-Torregroza

Zuleima Yáñez-Torregroza

Auto-generated profile, based on publicly available information

Zuleima Yáñez-Torregroza

Simón Bolívar University, Colombia

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2012 in Human Mutation
Verified
Journal Article
Closed access
PDF file
CBConceição Bettencourt
Conceição Bettencourt
BQBeatriz Quintáns
Beatriz Quintáns
RRRaquel Ros
Raquel Ros
IAIsrael Ampuero
Israel Ampuero
ZYZuleima Yáñez
Zuleima Yáñez
MSMaría-Jesús Sobrido
María-Jesús Sobrido
Hereditary spastic paraplegias (HSPs) constitute a heterogeneous group of neurological disorders, characterized primarily by progressive spasticity and weakness of the lower limbs. HSPs are caused by mutations in multiple genes (at least 48 loci and 28 causative genes). The clinical spectrum of HSPs is wide and important differences have been reported between patients with distinct mutations in the same gene, or even between different family members bearing the same mutation. Many patients with HSP present clinical deficits related to the involvement of neuronal systems other than corticospinal tracts, namely, peripheral nerves, sensory, or cerebellar pathways. These cases may be difficult to differentiate from other neurological diseases (e.g., hereditary ataxias), also genetically and clinically heterogeneous. As an illustration of how overlapping this genotype–phenotype relationship is, and the difficulties that it brings upon the development of neurogenetic algorithms and databases, we review the main clinical and genetic features of HSPs, and summarize reports on cases of triplet‐repeat spinocerebellar ataxias that can mimic HSP phenotypes. This complex scenario makes the necessity of high‐quality, curated mutation databases even more urgent, in order to develop adequate diagnostic guidelines, correct interpretation of genetic testing, and appropriate genetic counseling. Hum Mutat 33:1315–1323, 2012.

3 September 2018 in Global Journal of Health Science
Verified
Journal Article
Open access
PDF file
ADAnderson Díaz-Pérez
Anderson Díaz-Pérez
ZYZuleima Yáñez-Torregroza
Zuleima Yáñez-Torregroza
JGJaime Lorduy Gómez
Jaime Lorduy Gómez
ICIdelsy Carrillo-Suárez
Idelsy Carrillo-Suárez
SMShirley Garcia Mora
Shirley Garcia Mora
INTRODUCTION: The reflection about the elements of communication that health professionals use strengthens the empathic relationship and therefore the actions that seek self-care in patients. Nursing schools must teach how to acquire competences from what should be (moral) to fully consider the emotions and needs of hospitalized children so that they can attend to the call of care. Nursing should tend to social and communication skills to offer a humanized care when children appeal to crying, to silence, to play, to attract attention. OBJECTIVE: Propose a framework of moral management of communication from the design of a functional communication structure model for the pediatric patient to come to the call of their care in a positive way. METHODOLOGY: Nature of qualitative study of descriptive type and symbolic interactionism (perceptual regression). The population was 44 nurses. The data was obtained by interviews analyzed by the STATGRAPHICS XVII Centurión Plus® and Atlas Ti 8.0 ® programs. CONCLUSION: The practices of nurses respond to the dynamics so that the child comes to the care when they are aware of the purpose of communication in strengthening the moral development of the child. A model of functional communication structure for pediatric patient care adjusted to the axioms of Paul Watzlawick is proposed.

29 April 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
APAnderson Diaz Perez
Anderson Diaz Perez
ZTZuleima Yáñez Torregroza
Zuleima Yáñez Torregroza
The Universal Declaration on the Human Genome and Human Rights gave genomics an enduring human-rights grammar built around dignity, equality, privacy, and the symbolic idea that the human genome is the heritage of humanity [1]. That grammar remains indispensable, but it is no longer sufficient. Contemporary genomic practices are not confined to laboratory science or bedside counseling: they unfold within data-intensive, computational, and commercially mediated infrastructures that classify persons, govern access to care, and redistribute risk across families, communities, and generations. This article asks a sharper question than the usual privacy-versus-innovation framing: what is the normative object of genomic rights under conditions of predictive biology? The article argues that genomic rights should be interpreted not merely as personality rights protecting individuals from misuse, but as governance rights aimed at shaping how genomic prediction, circulation, ownership, and benefit-sharing are organized. The argument proceeds in four steps. First, it reconstructs the normative architecture of the UNESCO framework and its connections with broader human-rights law, including privacy, equality, and the right to enjoy the benefits of scientific progress [1-6]. Second, it shows why mainstream approaches centered on consent, confidentiality, and anti-discrimination are necessary but analytically insufficient in the face of algorithmic profiling, cross-sector data drift, and unequal access to genomic benefit [7-10]. Third, it proposes four analytic concepts—algorithmic genomic biopower, conditional genomic sovereignty, anticipatory dignity, and multilevel genomic justice—as a vocabulary for contemporary governance. Fourth, it tests that framework against six boundary cases that reveal where conventional bioethics becomes descriptively weak or normatively thin [11-24]. The article concludes that the most important contemporary question is no longer whether genomics can be reconciled with human rights in principle, but who governs predictive biological futures, through which institutions, and for whose benefit. A rights-based response adequate to that problem must move from downstream protection toward upstream governance, from exclusively individual consent toward relational and collective accountability, and from formal access to innovation toward justice in the distribution of genomic risk and benefit.

28 March 2019 in Gaceta Médica de México
Verified
Journal Article
Closed access
MRMartha Rebolledo-Cobos
Martha Rebolledo-Cobos
ZYZuleima Yáñez-Torregroza
Zuleima Yáñez-Torregroza
Environmental carcinogens and human papillomavirus (HPV) are the main responsible factors for oral cancer. Susceptibility factors in the human genome play a risk-modulating role; however not all individuals exposed to these carcinogens suffer from cancer. The purpose of the present review is to describe the main factors of genetic susceptibility to oral cancer due to HPV infection. A systematic search was carried out in three databases in English, with only 7 articles meeting the selection criteria. Genetic polymorphisms are shown in three categories, which are related to HPV and participate in oncogenesis. Three articles related to deregulation of cell cycle control mechanisms were identified, as well as one referring to mutations in the apoptosis pathway and three about polymorphisms in inflammatory and immune response genes. The association of polymorphisms for the development of oral cancer by HPV is evident, although it remains under study. Oral neoplasms' oncogenesis pattern is not always associated with HPV, but with other environmental or epigenetic factors.